Features

  • For temporary external control of bleeding from indwelling catheters
  • Disc products are easy to use and fit a full range of catheter sizes, from 2.6 Fr – 18 Fr
  • Forms an instant seal over the insertion site to prevent oozing and bleeding
  • Creates a hostile barrier to microbial penetration over the site1
  • Does not rely on the clotting cascade and thus works for patients prone to bleeding
  • Keeps sites dry and intact until the scheduled dressing change2-4
  • Reduces unplanned dressing changes and the associated infection risk2-4
  • Prophylactic use has been shown to reduce infection rates by as much as 92% when included in a CLABSI reduction strategy2

Product codes

CodeProduct
DS624StatSeal® Small Disc – case of 24 applications
DM625StatSeal® Medium Disc – case of 24 applications
DL626StatSeal® Large Disc – case of 24 applications
DX627StatSeal® Extra Large Disc – case of 24 applications

How it works

StatSeal products are comprised of a hydrophilic polymer and potassium ferrate. As a manual pressure adjunct, StatSeal’s mechanism of action is two-step and occurs simultaneously to instantly form a low pH occlusive seal that acts as a physical barrier over the wound site, letting nothing in or out. The hydrophilic polymer rapidly dehydrates the blood and absorbs exudate, stacking up desiccated blood solids beneath to form a seal. The potassium ferrate binds the blood solids and proteins together, adhering the seal to the wound to stop bleeding and oozing. Beneath the seal the pH is neutral, and the blood solids and proteins continue to stack naturally. Above the seal, the hydrophilic polymer has a pH of 2 which creates a hostile barrier to microbial penetration.1,3

References: [1] Timsit JF, Bouadma L, Ruckly S, et al. Dressing disruption is a major risk factor for catheter-related infections. Crit Care Med. 2012 June;40(6):1707-14. [2] Olaechea PM, Palomar M, Alarez Lerma F, et al. Morbidity and mortality associated with primary and catheter-related blood stream infections in critically ill patients. Rev Esp Quimioter. 2013 Mar;26(1):21-9. [3] Olsen M, Morris M. Fresh Eyes Focused on Safety: Nurses Partner with Engineering Students to Eliminate CLABSIs in Cardiac Surgery Patients. Lecture presented at AVA Annual Meeting; October 4-7, 2019; Las Vegas, NV. [4] Wilder KA, Wall B, Haggard D, Epperson T. CLABSI Reduction References: [1] Biolife, LLC, 510(k) K080210, Section 18.3. [2] Wilder KA, Wall B, Haggard D, Epperson T. CLABSI Reduction Strategy: A Systematic Central Line Quality Improvement Initiative Integrating Line-Rounding Principles and a Team Approach. Adv Neonatal Care. 2016 Jun;16(3):170-7. [3] Blough L, Hinson K, Hen J. The science of a seal for PICC line management: bio seal CVC powder. J VAS Access. 2010;15(2):66-73. [4] Ayala, M. PICC Insertion Dressing Protocol for the Hematological Oncology Patient: A Comparison of Biopatch and StatSeal. Poster presented at AVA Annual Meeting; October 4-7, 2019; Las Vegas, NV.